Medpace 

€306.1
115
-€0.9-0.29% 今天

统计数据

当日最高
306.1
当日最低
306.1
52周最高
-
52周最低
-
成交量
0
平均成交量
-
市值
9.38B
市盈率
31.54
股息收益率
-
股息
-

即将到来

收益

21Oct预期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
2.31
2.54
2.77
3
预期每股收益
2.5254798961800002
实际每股收益
N/A

人们还关注

此列表基于关注01P.F的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
首席执行官
Dr. August James Troendle M.D.
员工
5800
国家
US
ISIN
US58506Q1094
WKN
000A2APTV

上市公司